World's Leading Manufacturer of Oral Rehydration Salts Chooses ValGenesis VLMS to Digitize Corporate Validation Process

SAN FRANCISCO, Jan. 8, 2019 /PRNewswire/ -- ValGenesis, Inc., a market leader in Enterprise Validation Lifecycle Management Solutions (VLMS), today announced that the world's leading manufacturer of Oral Rehydration Salts has chosen ValGenesis's 100% paperless Validation Lifecycle Management System to manage its validation lifecycle process.

A pioneer in the manufacture of specialized formulations, this company has been the world's leading manufacturer of ORS (Oral Rehydration Salts) since 1972 with globally approved, multilocation manufacturing facilities across India that develop cost-effective, environmentally friendly, high-quality Active Pharmaceutical Ingredients (APIs) and Finished Dosage Forms that meet stringent ICH standards. Having filed over 150 local and international patent applications to date, the company offers more than 300 products in India and exports many of them to over 50 countries across the globe. It was the first manufacturer in South East Asia to offer ophthalmic formulations using Blow-Fill-Seal (BFS) technology and has a marked presence in numerous therapeutic segments such as anti-infectives, gastrointestinal, ophthalmological, vitamins/minerals/dietary supplements, cardiac, anti-diabetes, respiratory, gynecology, dermatology, analgesics and others.

Realizing that traditional, manual, paper-based validation processes were proving both costly and inefficient, the company decided it was time to consider a paperless solution. It conducted a detailed evaluation of multiple solutions and selected the ValGenesis Enterprise VLMS—an electronic, paperless solution that well meets the company's validation lifecycle needs. With ValGenesis Enterprise VLMS, the company will significantly reduce validation cycle time, gain a higher standard of data integrity, improve regulatory compliance, and gain a holistic view of real-time validation statuses across its regulated systems, thereby improving the quality and speed of the entire process.

"A leading life science company based in India has selected our ValGenesis VLMS, which makes validation processes and activities seamless and transparent, thereby eliminating the need for time-consuming, costly and human intensive processes," says Narayan Raj, Vice President of ValGenesis Inc. "ValGenesis VLMS is a best-in-class software solution that offers all the benefits of an electronic system with necessary controls that adhere to global compliance needs, which is appealing to more and more global life science companies, such as this one. We are excited to see that our clients continue to confirm the depth and width of the functionality our solution offers to any electronic validation system."

About ValGenesis
ValGenesis, Inc. is the creator of an innovative software platform that serves as the foundation for managing compliance-based validation activities in life science companies. ValGenesis, Inc. is the provider of the first enterprise application that manages the corporate validation lifecycle process. As the first fully paperless solution for 100 % electronic management of validation execution and approval, ValGenesis was selected by an industry peer review committee to receive the Parenteral Drug Association (PDA) New Innovative Technology Award in 2005. The solution is also fully compliant with U.S. FDA 21 CFR Part 11 and Annex 11 requirements.

For more information, visit 

Further information:
Althea D'Sylva, ValGenesis Communications, +1 510-445-0505 Ex. 1026,


Cision View original content to download multimedia:

SOURCE ValGenesis Inc.

Back to news